EXO Trademark

Trademark Overview


On Friday, October 20, 2017, a trademark application was filed for EXO with the United States Patent and Trademark Office. The USPTO has given the EXO trademark a serial number of 87653103. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 5, 2022. This trademark is owned by Exopharm Pty Ltd. The EXO trademark is filed in the Pharmaceutical Products category with the following description:

Protein arrays and polypeptides for diagnosing age-related conditions including skin ageing and skin disease, wounds and impairments in wound healing, joint and tendon degeneration, cardio-vascular diseases, degenerative bone conditions and neurodegeneration; radiation induced tissue degeneration; impairments in trauma-induced healing; Pharmaceutical and Veterinary Preparations, Namely, amino acids and nucleic acids; Pharmaceutical and veterinary preparations, namely, lipids for use in treating or improving age-related conditions including skin ageing and skin disease, wounds and impairments in wound healing, joint and tendon degeneration, cardio-vascular diseases, degenerative bone conditions and neurodegeneration; radiation-induced tissue degeneration; trauma-induced healing
exo

General Information


Serial Number87653103
Word MarkEXO
Filing DateFriday, October 20, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "exo" in white in a blue circle.
Goods and ServicesProtein arrays and polypeptides for diagnosing age-related conditions including skin ageing and skin disease, wounds and impairments in wound healing, joint and tendon degeneration, cardio-vascular diseases, degenerative bone conditions and neurodegeneration; radiation induced tissue degeneration; impairments in trauma-induced healing; Pharmaceutical and Veterinary Preparations, Namely, amino acids and nucleic acids; Pharmaceutical and veterinary preparations, namely, lipids for use in treating or improving age-related conditions including skin ageing and skin disease, wounds and impairments in wound healing, joint and tendon degeneration, cardio-vascular diseases, degenerative bone conditions and neurodegeneration; radiation-induced tissue degeneration; trauma-induced healing
Pseudo MarkEXOPHARM
Indication of Colors claimedThe color(s) blue and white is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 30, 2017
Primary Code005
First Use Anywhere DateTuesday, January 3, 2017
First Use In Commerce DateFriday, February 3, 2017

Trademark Owner History


Party NameEXOPHARM LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressMELBOURNE VIC 3000
AU

Party NameExopharm Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBlackburn Victoria 3130
AU

Trademark Events


Event DateEvent Description
Tuesday, April 5, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 5, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 2, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 15, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, November 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 21, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 21, 2021FINAL REFUSAL E-MAILED
Tuesday, September 21, 2021FINAL REFUSAL WRITTEN
Wednesday, August 4, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, October 27, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 3, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 2, 2020ASSIGNED TO LIE
Tuesday, September 3, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 1, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 30, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 30, 2018LETTER OF SUSPENSION E-MAILED
Thursday, August 30, 2018SUSPENSION LETTER WRITTEN
Tuesday, August 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 8, 2018NON-FINAL ACTION E-MAILED
Thursday, February 8, 2018NON-FINAL ACTION WRITTEN
Wednesday, January 31, 2018ASSIGNED TO EXAMINER
Tuesday, October 31, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, October 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 24, 2017NEW APPLICATION ENTERED